NfL as a biomarker for neurodegeneration and survival in Parkinson disease.
David BäckströmJan LinderSusanna Jakobson MoKatrine RiklundHenrik ZetterbergKaj BlennowLars ForsgrenNiklas LenfeldtPublished in: Neurology (2020)
This study provides Class II evidence that in patients with PD, cNfL concentrations are associated with more severe disease and shorter survival.